Jane Street’s Genesis Healthcare, Inc. GEN Stock Holding History

Jane Street’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-132,006	Closed	-$72K	–	8437
2020 Q3	$72K	Sell	132,006 -220,754	-63%	-$159K	﹤0.01%	6835
2020 Q2	$243K	Buy	+352,760	New	+$284K	﹤0.01%	6136
2019 Q4	–	Sell	-10,300	Closed	-$11K	–	6045
2019 Q3	$11K	Sell	10,300 -56,801	-85%	-$65.7K	﹤0.01%	4970
2019 Q2	$83K	Buy	+67,101	New	+$85.4K	﹤0.01%	4887
2019 Q1	–	Sell	-35,077	Closed	-$41K	–	5919
2018 Q4	$41K	Sell	35,077 -3,779	-10%	-$5.61K	﹤0.01%	4743
2018 Q3	$52K	Sell	38,856 -3,478	-8%	-$5.51K	﹤0.01%	4920
2018 Q2	$97K	Buy	+42,334	New	+$81.8K	﹤0.01%	4739

Other funds holding GEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's GEN Position: Q4 2020 in Review

Jane Street sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 132,006 shares — an estimated $72K sold.

Jane Street first reported a position in GEN in Q2 2018 and held it in 7 quarters. The position peaked at $243K in Q2 2020. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

Jane Street reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
Jane Street sold 132,006 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $72K.
Jane Street first reported a position in Genesis Healthcare, Inc. in Q2 2018 and held it in 7 quarters.
Jane Street's Genesis Healthcare, Inc. position peaked at $243K in Q2 2020.
49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.